Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSA4 Protocol for Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
NCT00610883Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 1990
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, methotrexate, daunorubicin, asparaginase escherichia coli, carmustine in non-Hodgkin lymphoma (NHL), sponsored by Memorial Sloan Kettering Cancer Center. Started May 1990; status: completed.
02
Drugs
cyclophosphamidemethotrexatedaunorubicinasparaginase escherichia colicarmustine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00610883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610883.